Luitpold Warns Of Adequan I.m. Shortages
May 10, 2013
The drug has no generic equivalent and is the only polysulfated glycosaminoglycan approved by the U.S. Food and Drug Administration, Luitpold added. The plant renovations, intended to guarantee higher quality standards, depleted the supply of Adequan, the company stated. "We have carefully managed supply to allocate inventory optimally, but the product will be out of… Continue reading...